HyperPATH study cohort for all variables

Published: 21 November 2024| Version 1 | DOI: 10.17632/h588hz3pbt.1
Contributor:
Ezgi Caliskan Guzelce

Description

International Hypertensive Pathotype (HyperPATH) Consortium, HyperPATH study, has been an on-going, multi-site study, aimed at investigating the pathophysiologic and genotypic mechanisms involved in hypertension and cardiovascular diseases. Participants were studied at four collaborating centers: Brigham and Women’s Hospital (Boston, MA), University of Utah Medical Center (Salt Lake City, UT), Vanderbilt University Hospital (Nashville, TN), and Hôpital Européen Georges Pompidou (Paris, France).

Files

Institutions

Harvard Medical School, Harvard University

Categories

Cardiovascular Endocrinology, Sex Differentiation, Hypertension, Aldosterone

Licence